Medicalgorithmics S.A.
ISIN: PLMDCLG00015 | Ticker: MDG | LEI: 259400O65SLJ2CVTSP22
Country: Poland
Medicalgorithmics S.A. is a Polish company that develops advanced systems for cardiology. Innovation is one of its main advantages –it is present both in the organization of day-to-day work and in the development process. Thanks to a multidisciplinary group of researchers and developers, Medicalgorithmics markets ground-breaking technological solutions. We develop algorithms, software and devices which are then implemented for manufacturing. It lets us provide telemedicine services – arrhythmia diagnostics and cardiac telerehabilitation supervision – to thousands of patients around the world.
The Medicalgorithmics flagship product is PocketECG, a system for heart arrhythmia diagnostics, which has been successfully used by patients in the United States for 10 years. It has become one of the most popular systems for long-term heart monitoring. So far, PocketECG has diagnosed several hundred thousand patients in the U.S. and recorded 200 million hours of heart beating.
2005
Served areaWorldwide
HeadquartersAl. Jerozolimskie 81, 02-001 Warszawa – Poland
| Line item in (pln) | 02.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Assets | N/A | 114,410,000.00 | 108,736,000.00 |
| Noncurrent Assets | N/A | 77,664,000.00 | 65,943,000.00 |
| Property Plant And Equipment | N/A | 26,996,000.00 | 2,003,000.00 |
| Deferred Tax Assets | N/A | 0.00 | 0.00 |
| Current Assets | N/A | 36,746,000.00 | 42,793,000.00 |
| Inventories | N/A | 0.00 | 8,771,000.00 |
| Trade And Other Current Receivables | N/A | 25,079,000.00 | 7,857,000.00 |
| Cash and cash equivalents | 16,197,000.00 | 11,667,000.00 | 26,165,000.00 |
| Equity And Liabilities | N/A | 114,410,000.00 | 108,736,000.00 |
| Equity | 207,365,000.00 | 47,394,000.00 | 80,079,000.00 |
| Issued Capital | N/A | 498,000.00 | 995,000.00 |
| Retained Earnings | N/A | -104,758,000.00 | -135,340,000.00 |
| Other Reserves | N/A | 148,123,000.00 | 210,982,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 47,385,000.00 | 80,070,000.00 |
| Noncontrolling Interests | N/A | 9,000.00 | 9,000.00 |
| Liabilities | N/A | 67,016,000.00 | 28,657,000.00 |
| Noncurrent Liabilities | N/A | 26,761,000.00 | 17,053,000.00 |
| Noncurrent Provisions | N/A | 105,000.00 | 191,000.00 |
| Accruals Classified As Noncurrent | N/A | 3,227,000.00 | 4,178,000.00 |
| Deferred Tax Liabilities | N/A | 4,378,000.00 | 8,293,000.00 |
| Other Noncurrent Financial Liabilities | N/A | 10,784,000.00 | 4,244,000.00 |
| Other Noncurrent Liabilities | N/A | 144,000.00 | 147,000.00 |
| Longterm Borrowings | N/A | 8,123,000.00 | 0.00 |
| Current Liabilities | N/A | 40,255,000.00 | 11,604,000.00 |
| Current Provisions | N/A | 3,200,000.00 | 641,000.00 |
| Trade And Other Current Payables | N/A | 18,416,000.00 | 5,788,000.00 |
| Accruals Classified As Current | N/A | 8,999,000.00 | 35,000.00 |
| Current Tax Liabilities Current | N/A | 113,000.00 | 125,000.00 |
| Other Current Financial Liabilities | N/A | 8,008,000.00 | 5,006,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 1,519,000.00 | 9,000.00 |
| Line item in (pln) | 01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|
| Revenue | 48,349,000.00 | 62,719,000.00 |
| Raw Materials And Consumables Used | 9,918,000.00 | 12,354,000.00 |
| Services Expense | 8,695,000.00 | 12,218,000.00 |
| Employee Benefits Expense | 12,893,000.00 | 17,093,000.00 |
| Depreciation And Amortisation Expense | 4,187,000.00 | 4,020,000.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | -21,737,000.00 | 0.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | -21,737,000.00 | 0.00 |
| Other Expense By Nature | 497,000.00 | 657,000.00 |
| Profit Loss From Operating Activities | -9,635,000.00 | 17,212,000.00 |
| Finance Income | 3,245,000.00 | 955,000.00 |
| Finance Costs | 620,000.00 | 295,000.00 |
| Profit Loss Before Tax | -7,010,000.00 | 17,872,000.00 |
| Income Tax Expense Continuing Operations | -438,000.00 | -216,000.00 |
| Profit Loss From Continuing Operations | -6,572,000.00 | 18,088,000.00 |
| Profit Loss From Discontinued Operations | -174,066,000.00 | -48,492,000.00 |
| Profit (loss) | -180,638,000.00 | -30,404,000.00 |
| Profit Loss Attributable To Owners Of Parent | -180,638,000.00 | -30,404,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 0.00 | 0.00 |
| Line item in (pln) | 01.01.2022 | 02.01.2021 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | -180,638,000.00 | N/A | -30,404,000.00 |
| Adjustments For Income Tax Expense | -17,343,000.00 | N/A | -1,804,000.00 |
| Adjustments For Decrease Increase In Inventories | 0.00 | N/A | -1,633,000.00 |
| Adjustments For Increase Decrease In Other Operating Payables | -13,855,000.00 | N/A | 5,867,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 162,283,000.00 | N/A | 1,148,000.00 |
| Adjustments For Provisions | 332,000.00 | N/A | 335,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -4,474,000.00 | N/A | 3,679,000.00 |
| Other Adjustments For Noncash Items | -2,499,000.00 | N/A | 11,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | -85,000.00 | N/A | 0.00 |
| Interest Received Classified As Operating Activities | 607,000.00 | N/A | 0.00 |
| Income Taxes Paid Refund Classified As Operating Activities | -2,216,000.00 | N/A | -2,144,000.00 |
| Other Inflows Outflows Of Cash Classified As Operating Activities | 11,000.00 | N/A | 46,000.00 |
| Cash Flows From Used In Operating Activities | -6,479,000.00 | N/A | 6,331,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | 0.00 | N/A | 19,957,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 9,910,000.00 | N/A | 0.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | 5,969,000.00 | N/A | 12,374,000.00 |
| Proceeds From Other Longterm Assets Classified As Investing Activities | 103,000.00 | N/A | 0.00 |
| Cash Flows From Used In Investing Activities | -15,776,000.00 | N/A | -1,812,000.00 |
| Proceeds From Issuing Shares | 11,447,000.00 | N/A | 13,870,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | 0.00 | N/A | 0.00 |
| Repayments Of Borrowings Classified As Financing Activities | 1,536,000.00 | N/A | 1,477,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 5,233,000.00 | N/A | 0.00 |
| Proceeds From Government Grants Classified As Financing Activities | 15,087,000.00 | N/A | 0.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | 0.00 | N/A | -763,000.00 |
| Cash Flows From Used In Financing Activities | 17,725,000.00 | N/A | 9,979,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | -4,530,000.00 | N/A | 14,498,000.00 |
| Cash and cash equivalents | 11,667,000.00 | 16,197,000.00 | 26,165,000.00 |
Please note that some sums might not add up.
PLMDCLG00015
LEI259400O65SLJ2CVTSP22
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.